Almond Pharma operates under a UK Wholesale Dealer’s Authorisation (Human) [WDA(H)], delivering compliant, efficient, and responsive pharmaceutical distribution across the UK, EU, and global markets.
Our model is built around shortage medicine supply, international trade, and warehouse-to-warehouse (W2W) distribution, ensuring critical medicines reach healthcare providers without delay.
Shortage Medicines Specialists
Medicine shortages place significant pressure on healthcare systems and patient care. Almond Pharma is purpose-built to respond to this challenge.
We specialise in the identification, sourcing, and supply of shortage and hard-to-find medicines, ensuring continuity of care across healthcare settings.
Our approach enables us to:
- Source out-of-stock and limited-availability medicines through global networks
- Respond rapidly to urgent procurement requirements
- Support wholesalers, pharmacies, and healthcare providers with reliable access to essential treatments
- Reduce supply disruption through proactive sourcing strategies
International Trade & Global Importation
Almond Pharma delivers fully compliant import and export solutions across global pharmaceutical markets, connecting verified supply with urgent demand across borders.
Leveraging a network of pre-qualified partners across the EU and international markets, we source and distribute medicines aligned with MHRA, EMA, and internationally recognised regulatory standards.
Our international trade capability ensures:
- Efficient cross-border movement of medicines
- Full compliance with GDP and regulatory requirements
- Robust documentation, traceability, and quality assurance
- Access to global inventory pools, unlocking supply where local shortages exist
We enable healthcare providers to access medicines beyond geographical limitations, ensuring patients receive treatment when it is needed most.
Warehouse-to-Warehouse (W2W) Distribution
Our warehouse-to-warehouse (W2W) model allows direct distribution between licensed pharmaceutical facilities, reducing delays, minimising handling risks, and maintaining full supply chain integrity.
Through this approach, we:
- Facilitate direct transfers between approved wholesalers and partners
- Maintain product integrity across ambient and controlled supply chains
- Reduce intermediaries, improving speed and efficiency
- Ensure end-to-end traceability and GDP compliance
This streamlined logistics model enables faster response times, particularly critical in the supply of shortage medicines.
Our Approach
Almond Pharma bridges the gap between global supply and local demand, combining regulatory expertise, logistics efficiency, and a strong international partner network.
By integrating shortage sourcing, international trade, and W2W distribution, we provide a responsive and reliable solution to modern pharmaceutical supply challenges—ensuring continuity, compliance, and patient safety at every stage.

